Cross Country Healthcare

CCRN

Market cap $421M

Investors interested in Staffing Firms stocks are likely familiar with Kelly Services (KELYA) and Cross Country Healthcare (CCRN). But which of these two companies is the best option for those looking for undervalued stocks?

AGL, PLAY and CCRN have been added to the Zacks Rank #5 (Strong Sell) List on October 1, 2025.

AGL, CCRN and GOGL have been added to the Zacks Rank #5 (Strong Sell) List on August 20, 2025.

Cross Country Healthcare (CCRN 2.02%), a major provider of healthcare staffing solutions, reported its second quarter results on August 6, 2025. The company reported a substantial miss on both GAAP revenue and non-GAAP EPS.

Cross Country Healthcare (CCRN) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of $0.07. This compares to earnings of $0.1 per share a year ago.

BOCA RATON, Fla.--(BUSINESS WIRE)--Cross Country Healthcare, Inc. (the Company) (Nasdaq: CCRN) today announced financial results for its second quarter ended June 30, 2025. Selected Financial Information:     Variance Variance     Q2 2025 vs Q2 2025 vs Dollars are in thousands, except per share amounts Q2 2025 Q2 2024 Q1 2025 Revenue $ 274,072     (19 )%   (7 )% Gross profit margin*   20.4 %   (40 )bps   40 bps Net loss attributable to common stockholders $ (6,659 )   (59 )%   (1,259 )% Diluted.

Cross Country (CCRN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

I previously rated CCRN a sell, arguing that the FTC could block the merger because of concerns about competition in healthcare markets. The stock price now offers a 45% upside if the Aya merger closes, with the market pricing in only a 22% chance of the deal completing. Management continues to guide toward the deal completing in the second half of 2025.

Cross Country Healthcare (CCRN) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of $0.04 per share. This compares to earnings of $0.19 per share a year ago.

BOCA RATON, Fla.--(BUSINESS WIRE)--Cross Country Healthcare, Inc. (the Company) (Nasdaq: CCRN) today announced financial results for its first quarter ended March 31, 2025. SELECTED FINANCIAL INFORMATION:       Variance Variance       Q1 2025 vs Q1 2025 vs Dollars are in thousands, except per share amounts Q1 2025 Q1 2024 Q4 2024 Revenue $ 293,408       (23 ) %   (5 ) % Gross profit margin*   20.0   %   (40 ) bps   —   bps Net loss attributable to common stockholders $ (490 )     (118 ) %   87.